Autolus Therapeutics plc
AUTL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $86 | $124 | $96 | $227 |
| Short-Term Investments | $281 | $330 | $421 | $361 |
| Receivables | $91 | $79 | $14 | $48 |
| Inventory | $28 | $24 | $15 | $4 |
| Other Curr. Assets | $28 | $17 | $70 | $21 |
| Total Curr. Assets | $515 | $574 | $616 | $661 |
| Property Plant & Equip (Net) | $123 | $125 | $114 | $105 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $20 | $13 | $12 | $12 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $2 | $2 | $3 | $3 |
| Other NC Assets | $1 | $6 | $1 | $1 |
| Total NC Assets | $147 | $147 | $131 | $122 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $662 | $721 | $746 | $783 |
| Liabilities | – | – | – | – |
| Payables | $11 | $5 | $4 | $2 |
| Short-Term Debt | $5 | $3 | $3 | $3 |
| Tax Payable | $4 | $4 | $4 | $4 |
| Deferred Revenue | $8 | $2 | $5 | $0 |
| Other Curr. Liab. | $55 | $53 | $51 | $52 |
| Total Curr. Liab. | $83 | $68 | $67 | $61 |
| LT Debt | $61 | $61 | $308 | $50 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $252 | $245 | $0 | $245 |
| Total NC Liab. | $313 | $306 | $309 | $295 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $66 | $65 | $58 | $53 |
| Total Liabilities | $396 | $375 | $375 | $355 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,296 | -$1,217 | -$1,169 | -$1,099 |
| AOCI | -$5 | $1 | -$18 | -$29 |
| Other Equity | $1,567 | $1,563 | $1,559 | $1,556 |
| Total Equity | $265 | $346 | $371 | $427 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $662 | $721 | $746 | $783 |
| Net Debt | -$20 | -$59 | $215 | -$175 |